KeViRx, Inc.
PrivateLast Round
Accelerator
Aug 28, 2024
Total Funding Raised
$3.05M
Company Overview
KeViRx, Inc. is a biotechnology company that develops small molecule drugs to treat microvascular leakage and inflammation for diseases such as acute lung injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KeViRx, Inc. Comparables
Compare KeViRx, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vasomune Therapeutics | 88% | |
| CMTx Biotech, Inc. | 79% | |
| Aqualung Therapeutics Corporation | 78% | |
KeViRx, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 28, 2024 | ||||
| Grant | Jun 11, 2024 | ||||
| Grant | Aug 29, 2022 | ||||
| Accelerator | Feb 18, 2022 | ||||
| Grant | Oct 5, 2021 | ||||
Grant | Jun 15, 2020 |
Key People
Founding team and executive leadership
KeViRx, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Activation Capital | Accelerator |
| gener8tor | Accelerator |
| NIH RADx | Grant |
| U.S. Department of Defense | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Accelerator |
| Virginia Innovation Partnership Corporation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 11, 2024
Secured $2M from the U.S. Department of Defense and Department of War.
- Aug 29, 2022
$75K grant from Virginia Innovation Partnership Corporation
KeViRx, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KeViRx, Inc.'s valuation, stock price, and market status.